146 related articles for article (PubMed ID: 22108905)
21. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
[TBL] [Abstract][Full Text] [Related]
22. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.
Moon JW; Choi JH; Lee SK; Lee YW; Lee JO; Kim N; Lee HJ; Seo JS; Kim J; Kim HS; Kim GJ; Park SH
Cancer Genet; 2015 May; 208(5):261-70. PubMed ID: 26002729
[TBL] [Abstract][Full Text] [Related]
24. Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer.
Ma Y; Chen Y; Petersen I
Pathol Res Pract; 2017 Apr; 213(4):333-338. PubMed ID: 28214209
[TBL] [Abstract][Full Text] [Related]
25. CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer.
Wang Z; Yuan X; Jiao N; Zhu H; Zhang Y; Tong J
Pathol Oncol Res; 2012 Apr; 18(2):263-70. PubMed ID: 21796503
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.
Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967
[TBL] [Abstract][Full Text] [Related]
28. CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients.
Harder J; Engelstaedter V; Usadel H; Lassmann S; Werner M; Baier P; Otto F; Varbanova M; Schaeffner E; Olschewski M; Blum HE; Opitz OG
Br J Cancer; 2009 Jan; 100(2):360-5. PubMed ID: 19142184
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
30. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
31. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer.
Trojan J; Brieger A; Raedle J; Esteller M; Zeuzem S
Gut; 2000 Aug; 47(2):272-6. PubMed ID: 10896921
[TBL] [Abstract][Full Text] [Related]
32. Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study.
Yamashita K; Waraya M; Kim MS; Sidransky D; Katada N; Sato T; Nakamura T; Watanabe M
PLoS One; 2014; 9(12):e113546. PubMed ID: 25469504
[TBL] [Abstract][Full Text] [Related]
33. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S
Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674
[TBL] [Abstract][Full Text] [Related]
35. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
[TBL] [Abstract][Full Text] [Related]
36. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
37. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
Fukutomi S; Seki N; Koda K; Miyazaki M
Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
[TBL] [Abstract][Full Text] [Related]
38. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
39. MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues.
Okudaira K; Kakar S; Cun L; Choi E; Wu Decamillis R; Miura S; Sleisenger MH; Kim YS; Deng G
Int J Oncol; 2010 Apr; 36(4):765-75. PubMed ID: 20198318
[TBL] [Abstract][Full Text] [Related]
40. CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer.
Abdelmaksoud-Dammak R; Saadallah-Kallel A; Miladi-Abdennadher I; Ayedi L; Khabir A; Sallemi-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2016 Feb; 37(2):1707-14. PubMed ID: 26314856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
